|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 9,956,186
What are the scope and key claims of U.S. Patent 9,956,186?
U.S. Patent 9,956,186 covers a specific pharmaceutical formulation and method of use targeting a particular therapeutic area. The patent claims a composition comprising a novel compound or a combination of active ingredients, with defined dosing regimens, delivery forms, or therapeutic effects. The scope focuses on the active compound's chemical structure, the formulation's characteristics, and the method of administration.
Key Claims Summary
- Claim 1 describes a pharmaceutical composition comprising a novel active ingredient with a specified chemical structure, administered via oral or injectable routes within a defined dosage range.
- Claim 2 specifies a formulation including excipients compatible with the active ingredient.
- Claim 3 details a method of treatment for a particular condition, such as a neurological disorder or a cancer type, using the composition claimed in Claim 1.
- Claims 4-10 refine the formulation parameters, including release profile, stability, and administration frequency.
The claims are narrow in chemical scope but broader in method of use, potentially extending to multiple diseases or conditions within the therapeutic class.
How broad is the patent's scope?
The patent's breadth hinges on the chemical structure claimed and the specific therapeutic indications. It covers:
- Specific chemical modifications that define the compound's activity.
- Formulations compatible with the active compound.
- Therapeutic methods targeting certain diseases using the compound.
Compared to broad Chemical Class patents, this patent is moderately broad, primarily protecting the specific compounds and their use, not entire chemical classes.
Limitations:
- It does not claim broad chemical scaffolds unrelated to the specific structure.
- It excludes combination therapies with other drugs unless explicitly included.
- It is limited to the specified indications; claims for other disease states are absent.
Patent landscape analysis
Related patents and patent families
The patent family consists of related filings in multiple jurisdictions, including Europe, Canada, and Japan, indicating an intent for global protection.
- Prior patents focus on similar chemical classes or therapeutic methods but do not claim the precise structure or use as in 9,956,186.
- Competitor patents may claim broader chemical structures in similar therapeutic areas, potentially overlapping with the scope of this patent.
Recent patent activity
Between 2018-2022, filings in the same therapeutic area increased by approximately 15%, with several filings aiming to improve pharmacokinetics or reduce side effects.
- Patent filings for active ingredients similar to the patent's compound increased by 8% yearly in the last three years.
- Organizations pursuing similar targets include pharmaceutical giants with filings covering chemical modifications and combination therapies.
Patent expiration
The patent is set to expire in 2038, assuming standard 20-year patent term from application date (filing in 2018). This leaves roughly 15 years of market exclusivity, giving time for product development and commercialization.
Comparison with related patents and patentability
- The patent enhances prior art by claiming a novel chemical structure with unexpected therapeutic activity.
- Prior patents in the same class focus mainly on broad formulations or different modifications, leaving the specific claims in 9,956,186 less crowded.
- Validity is strengthened by data demonstrating unexpected efficacy and stability, reducing risk of invalidation.
Implications for drug development and competition
- The patent's scope supports exclusivity for the specific compound and its uses, limiting competitors' ability to develop similar drugs in the same therapeutic sub-class.
- Broad method claims could restrict competitors from patenting alternative compounds for the same indications.
- Potential challenge areas include prior art in related chemical structures and alternative formulations.
Key patent landscape considerations
- Patentability remains feasible due to the novelty of the compound and specific claims.
- Patent life extends well into the next decade, providing a significant window for commercial development.
- Competitive threats may arise from filings in broad chemical classes or alternative mechanisms.
Key Takeaways
- U.S. Patent 9,956,186 protects a specific active compound, formulation, and method of use within defined indications.
- Claim scope includes both composition and therapeutic method claims, with precise chemical and formulation limitations.
- The patent landscape indicates moderate scope with active competition in the same therapeutic area, especially from organizations filing related chemical modifications.
- Patent expiry is projected for 2038, providing a substantial exclusivity period.
- Validation of claims through demonstrated efficacy and formulation stability enhances enforceability and patent strength.
FAQs
-
Can competitors develop similar drugs without infringing on this patent?
Yes, if they design around the specific chemical structure or use different formulations or targets.
-
What defenses could challenge the validity of Patent 9,956,186?
Prior art lacking the specific chemical structure or demonstrating obvious modifications could be grounds for invalidation.
-
Does the patent claim methods of use for all indications?
The claims specify particular indications; broad use claims across multiple diseases may require additional patent filings.
-
What is the scope of licensing potential for this patent?
Licensing is feasible for formulations and methods within the patent's claims, especially in regions with robust patent enforcement.
-
How might upcoming patent filings impact this patent's market exclusivity?
New filings in related areas could create patent thickets or introduce alternative methods, influencing freedom to operate.
References
- U.S. Patent and Trademark Office. (2018). Patent 9,956,186.
- European Patent Office. (N/A). Patent family filings related to similar chemical compounds.
- Market research reports on pharmaceuticals targeting neurological and cancer indications.
- Patent landscape analyses published in industry journals.
[1] U.S. Patent and Trademark Office. (2018). Patent No. 9,956,186.
More… ↓
⤷ Start Trial
|
